HFS
KRYS icon

Hughes Financial Services’s Krystal Biotech KRYS Stock Holding History

Hughes Financial Services’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35K Buy
9
+4
+80% +$1.2K ﹤0.01% 632
2026
Q1 		$1.29K Buy
5
+1
+25% +$266 ﹤0.01% 700
2025
Q4 		$986 Hold
4
– – ﹤0.01% 718
2025
Q3 		$798 Hold
4
– – ﹤0.01% 778
2025
Q2 		$544 Buy
+4
New +$588 ﹤0.01% 922

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hughes Financial Services's KRYS Position: Q2 2026 in Review

Hughes Financial Services increased its Krystal Biotech (KRYS) stake by 80% in Q2 2026, buying an estimated $1.2K and bringing the position to 9 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #632.

Hughes Financial Services first reported a position in KRYS in Q2 2025 and has held it in 5 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Hughes Financial Services held 9 shares of Krystal Biotech worth $3.35K as of Q2 2026.
  • Hughes Financial Services bought 4 Krystal Biotech shares in Q2 2026, an estimated $1.2K.
  • Krystal Biotech made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #632 holding.
  • Hughes Financial Services first reported a position in Krystal Biotech in Q2 2025 and has held it in 5 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.